VEGFA and gastric cancer: Since gastric cancer (GC) express high VEGF and the 5-year survival of mGC with conventional chemotherapeutic agents is approximately 3.9% 4, targeting VEGF is therefore considered as an interesting therapeutic strategy for GC, especially metastatic gastric cancer (mGC).